Hydroxyzine Injection
Last Updated: March 23, 2015
Status: Current
Products Affected - Description
Hydroxyzine injection, American Regent
25 mg/mL, 1 mL vial (NDC 00517-4201-25)
50 mg/mL, 1 mL vial (NDC 00517-5601-25)
50 mg/mL, 2 mL vial (NDC 00517-5602-25)
50 mg/mL, 10 mL multiple-dose vial (NDC 00517-5610-25)
Reason for the Shortage
- American Regent has hydroxyzine injection on shortage due to manufacturing delays.
- American Regent is the sole supplier of hydroxyzine injection.
Available Products
No presentations are available.
Estimated Resupply Dates
American Regent has hydroxyzine 25 mg/mL 1 mL vials and hydroxyzine 50 mg/mL 1 mL, 2 mL, and 10 mL vials on back order and the company cannot estimate a release date.
Related Shortages
- Amobarbital Injection — Resolved
- Chloral Hydrate Oral Solution and Capsules — No Longer Available
- Dexmedetomidine Injection — Resolved
- Droperidol Injection — No Commercially Available Preparations
- Lorazepam injectable presentations — Current
- Midazolam Injections — Current
Updated
January 16, 2015; October 21, 2014; August 8, 2014; May 6, 2014; February 10, 2014; November 12, 2013; September 9, 2013; July 12, 2013; June 18, 2013; May 30, 2013; April 24, 2013; March 27, 2013; February 21, 2013, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.
